May 07, 2020
World Market for Allergy Relieving Eye Drops: Forecasts and Coverage of Key Players Including Allergan, Pfizer and Regeneron Pharmaceuticals
Mar 30, 2020
Eyevance Pharmaceuticals Launches ZERVIATE(TM) in the United States
Mar 26, 2019
Johnson & Johnson Vision's Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Results
Mar 26, 2019
Aldeyra Therapeutics Announces Positive Top-Line Results from the Phase 3 ALLEVIATE Trial in Patients with Allergic Conjunctivitis
Mar 25, 2019
Aldeyra Therapeutics Schedules Webcast and Conference Call to Announce Top-Line Results from the Phase 3 ALLEVIATE Trial in Allergic Conjunctivitis
Feb 28, 2019
Aldeyra Therapeutics Provides Update on Ophthalmic Programs at 2019 Research & Development Day
Feb 25, 2019
Allergy relieving Eye Drops Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Dec 20, 2018
Aldeyra Therapeutics Announces Last Patient Dosed in the ALLEVIATE Phase 3 Clinical Trial
Dec 04, 2018
Juntendo University Research: Omega-3 Fatty Acids Suppress Allergic Conjunctivitis Symptoms
May 15, 2018
Aldeyra Therapeutics Announces First Quarter 2018 Financial Results
May 07, 2018
Sylentis Announces New Data on the Treatment of Allergic Conjunctivitis
Apr 24, 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
Mar 29, 2018
Aldeyra Therapeutics Announces Year End 2017 Financial Results
Mar 12, 2018
Realm Therapeutics Provides Clinical Update, including Results from a Phase 2 Study of PR013 in Allergic Conjunctivitis
Feb 21, 2018
Aldeyra Therapeutics Selected for Podium Presentation of Phase 2a Dry Eye Disease Results at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Jan 30, 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Dry Eye Disease Phase 2b Clinical Trial
Dec 12, 2017
Realm Therapeutics Announces First Patient Dosed in Phase 2 Study of PR013 for the Treatment of Allergic Conjunctivitis
Nov 29, 2017
Aldeyra Therapeutics Presents Noninfectious Anterior Uveitis Phase 2 Clinical Trial Data to the American Uveitis Society Held at the American Academy of Ophthalmology 2017 Annual Meeting
Nov 09, 2017
Aldeyra Therapeutics Announces Third Quarter 2017 Financial Results
Oct 10, 2017
Aldeyra Therapeutics Announces New Data at 2017 Research & Development Day